Skip to main content
SpringerLink
Log in

Gold-Based Mucosal Nanovaccines

  • Chapter
  • First Online:
Book cover Nanovaccines

Abstract

The development of new, efficacious subunit vaccines depends on the availability of adjuvants and delivery vehicles that favor proper antigen delivery and immunostimulation, able to provoke robust adaptive immune responses. Moreover, vaccines administered by non-parenteral routes are highly desirable due to costs reduction and high patient compliance. Gold nanoparticles (AuNPs) are biocompatible materials that can be conjugated with antigens, rendering attractive vaccine candidates. In this chapter, the state of the art on the development of AuNPs-based vaccines is transmitted along with a description of the synthesis and bioconjugation approaches applied in this technology. Promising AuNPs-based vaccine candidates developed thus far comprise vaccines against influenza, glanders, and tetanus; these vaccine candidates have been characterized at the preclinical level with promising findings in terms of protection against the target disease in animal models. Key perspectives for this field are also identified.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abad JM, Mertens SFL, Pita M et al (2005) Functionalization of thioctic acid-capped gold nanoparticles for specific immobilization of histidine-tagged proteins. J Am Chem Soc 127:5689–5694

    Article  CAS  Google Scholar 

  • Almeida JP, Figueroa ER, Drezek RA (2014) Gold nanoparticle mediated cancer immunotherapy. Nanomedicine 10(3):503–514

    Article  CAS  Google Scholar 

  • Andreescu D, Sau TK, Goia DV (2006) Stabilizer-free nanosized gold sols. J Colloid Interface Sci 298:742–751

    Article  CAS  Google Scholar 

  • Barhate G, Gautam M, Gairola S, Jadhav S, Pokharkar V (2014) Enhanced mucosal immune responses against tetanus toxoid using novel delivery system comprised of chitosan-functionalized gold nanoparticles and botanical adjuvant: characterization, immunogenicity, and stability assessment. J Pharm Sci 103(11):3448–3456

    Article  CAS  Google Scholar 

  • Barrett S (2004) Eradication versus control: the economics of global infectious disease policies. Bull World Health Organ 82:683–688

    Google Scholar 

  • Bhumkar DR, Joshi HM, Sastry M, Pokharkar VB (2007) Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm Res 24(8):1415–1426

    Article  CAS  Google Scholar 

  • Bloom D, Canning D, Weston M (2005) The value of vaccination. World Econ 6:15–39

    Google Scholar 

  • Boraschi D, Italiani P (2015) From antigen delivery system to adjuvanticy: the board application of nanoparticles in vaccinology. Vaccines (Basel) 3(4):930–939

    Article  CAS  Google Scholar 

  • Brandenberger C, Rothen-Rutishauser B, Mühlfeld C et al (2010) Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model. Toxicol Appl Pharmacol 242(1):56–65

    Article  CAS  Google Scholar 

  • Cappellano G, Comi C, Chiocchetti A, Dianzani U (2019) Exploiting PLGA-based biocompatible nanoparticles for next-generation tolerogenic vaccines against autoimmune disease. Int J Mol Sci 20(1):pii: E204. https://doi.org/10.3390/ijms20010204

    Article  CAS  Google Scholar 

  • Cohn L, Delamarre L (2014) Dendritic cell-targeted vaccines. Front Immunol 5:255

    Article  CAS  Google Scholar 

  • Dul M, Nikolic T, Stefanidou M, McAteer MA, Williams P, Mous J, Roep BO, Kochba E, Levin Y, Peakman M, Wong FS, Dayan CM, Tatovic D, Coulman SA, Birchall JC, EE-ASI Consortium (2019) Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy. Int J Pharm 562:303–312

    Article  CAS  Google Scholar 

  • El-Sayed IH, Huang X, El-Sayed MA (2005) Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett 5:839–834

    Article  CAS  Google Scholar 

  • Erak M, Bellmann-Sickert K, Els-Heindl S, Beck-Sickinger AG (2018) Peptide chemistry toolbox - transforming natural peptides into peptide therapeutics. Bioorg Med Chem 26(10):2759–2765

    Article  CAS  Google Scholar 

  • Fytianos K, Rodriguez-Lorenzo L, Clift MJ et al (2015) Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. Nanomedicine 11(3):633–644

    Article  CAS  Google Scholar 

  • Gargett T, Abbas MN, Rolan P, Price JD, Gosling KM, Ferrante A, Ruszkiewicz A, Atmosukarto IIC, Altin J, Parish CR, Brown MP (2018) Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma. Cancer Immunol Immunother 67(9):1461–1472

    Article  CAS  Google Scholar 

  • Gregory AE, Judy BM, Qazi O et al (2015) A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei. Nanomedicine 11(2):447–456

    Article  CAS  Google Scholar 

  • Hillyer JF, Albrecht RM (2001) Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 90:1927–1936

    Article  CAS  Google Scholar 

  • Hu M, Qian L, Brinãs RP, et al. (2007) Protein assembly through site-specific interactions with gold nanoparticles. MRS Proceedings, 951, Cambridge University Press

    Google Scholar 

  • Huckaby JT, Lai SK (2018) PEGylation for enhancing nanoparticle diffusion in mucus. Adv Drug Deliv Rev 124:125–139

    Article  CAS  Google Scholar 

  • Kamnev AA, Dykman LA, Tarantilis PA, Polissiou MG (2002) Spectroimmunochemistry using colloidal gold bioconjugates. Biosci Rep 22:541–547

    Article  CAS  Google Scholar 

  • Khan AU, Khan M, Malik N, Cho MH, Khan MM (2019) Recent progress of algae and blue-green algae-assisted synthesis of gold nanoparticles for various applications. Bioprocess Biosyst Eng 42(1):1–15

    Article  CAS  Google Scholar 

  • Liang X, Wei H, Cui Z, Deng J, Zhang Z, You X, Zhang XE (2011) Colorimetric detection of melamine in complex matrices based on cysteamine-modified gold nanoparticles. Analyst 136(1):179–183

    Article  CAS  Google Scholar 

  • Loo C, Hirsh L, Lee M et al (2005) Gold nanoshell bioconjugates for molecular imaging in living cells. Opt Lett 30:1012–1014

    Article  CAS  Google Scholar 

  • Muruato LA, Tapia D, Hatcher CL, Kalita M, Brett PJ, Gregory AE, Samuel JE, Titball RW, Torres AG (2017) The use of reverse vaccinology in the design and construction of nano-glycoconjugate vaccines against Burkholderia pseudomallei. Clin Vaccine Immunol 24(11):e00206–e00217

    Article  CAS  Google Scholar 

  • Niidome T, Nakashima K, Takahashi H, Niidome Y (2004) Preparation of primary amine-modified gold nanoparticles and their transfection ability into cultivated cells. Chem Commun 17:1978–1979

    Article  CAS  Google Scholar 

  • Oh E, Delehanty JB, Sapsford KE, Susumu K, Goswami R, Blanco-Canosa JB et al (2011) Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. ACS Nano 5(8):6434–6448

    Article  CAS  Google Scholar 

  • Ouellette M, Masse F, Lefebvre-Demers M, Maestracci Q, Grenier P, Millar R, Bertrand N, Prieto M, Boisselier É (2018) Insights into gold nanoparticles as a mucoadhesive system. Sci Rep 8(1):14357

    Article  CAS  Google Scholar 

  • Paciotti GF, Myer L, Weinreich D et al (2004) Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 11:169–183

    Article  CAS  Google Scholar 

  • Pal A, Shah S, Devi S (2007) Synthesis of Au, Ag and Au–Ag alloy nanoparticles in aqueous polymer solution. Colloids Surf A Physicochem Eng Asp 302:51–57

    Article  CAS  Google Scholar 

  • Pearson RM, Podojil JR, Shea LD, King NJ, Miller SD, Getts DR (2019) Overcoming challenges in treating autoimmuntity: development of tolerogenic immune-modifying nanoparticles. Nanomedicine 18:282–291

    Article  CAS  Google Scholar 

  • Pokharkar V, Bhumkar D, Suresh K et al (2011) Gold nanoparticles as a potential carrier for transmucosal vaccine delivery. J Biomed Nanotechnol 7(1):57–59

    Article  CAS  Google Scholar 

  • Quach QH, Ang SK, Chu JJ, Kah JCY (2018) Size-dependent neutralizing activity of gold nanoparticle-based subunit vaccine against dengue virus. Acta Biomater 78:224–235

    Article  CAS  Google Scholar 

  • Salazar-González JA, González-Ortega O, Rosales-Mendoza S (2015) Gold nanoparticles and vaccine development. Expert Rev Vaccines 14(9):1197–1211

    Article  CAS  Google Scholar 

  • Shah RR, Hassett KJ, Brito LA (2017) Overview of vaccine adjuvants: introduction, history, and current status. Methods Mol Biol 1494:1–13

    Article  CAS  Google Scholar 

  • Shakya AK, Chowdhury MYE, Tao W, Gill HS (2016) Mucosal vaccine delivery: current state and a pediatric perspective. J Control Release 240:394–413

    Article  CAS  Google Scholar 

  • Song WJ, Du JZ, Sun TM, Zhang PZ, Wang J (2010) Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery. Small 6(2):239–246

    Article  CAS  Google Scholar 

  • Staroverov SA, Volkov AA, Mezhenny PV, Domnitsky IY, Fomin AS, Kozlov SV, Dykman LA, Guliy OI (2019) Prospects for the use of spherical gold nanoparticles in immunization. Appl Microbiol Biotechnol 103(1):437–447

    Article  CAS  Google Scholar 

  • Sullivan SG, Price OH, Regan AK (2019) Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations. Ther Adv Vaccines Immunother 7:2515135519826481

    Google Scholar 

  • Tagliabue A, Rappuoli R (2018) Changing priorities in vaccinology: antibiotic resistance moving to the top. Front Immunol 9:1068

    Article  Google Scholar 

  • Tao W, Gill HS (2015) M2e-immobilized gold nanoparticles as influenza a vaccine: role of soluble M2e and longevity of protection. Vaccine 33(20):2307–2315

    Article  CAS  Google Scholar 

  • Tao W, Ziemer KS, Gill HS (2014) Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza a virus. Nanomedicine (Lond) 9(2):237–251

    Article  CAS  Google Scholar 

  • Tao W, Hurst BL, Shakya AK, Uddin MJ, Ingrole RS, Hernandez-Sanabria M, Arya RP, Bimler L, Paust S, Tarbet EB, Gill HS (2017) Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza a viruses. Antivir Res 141:62–72

    Article  CAS  Google Scholar 

  • Tello-Olea M, Rosales-Mendoza S, Campa-Córdova AI, Palestino G, Luna-González A, Reyes-Becerril M, Velazquez E, Hernandez-Adame L, Angulo C (2019) Gold nanoparticles (AuNP) exert immunostimulatory and protective effects in shrimp (Litopenaeus vannamei) against Vibrio parahaemolyticus. Fish Shellfish Immunol 84:756–767

    Article  CAS  Google Scholar 

  • Torres AG, Gregory AE, Hatcher CL et al (2015) Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine. Vaccine 33(5):686–692

    Article  CAS  Google Scholar 

  • Turkevich J (1985) Colloidal gold. Part 1: historical and preparative aspects, morphology and structure. Gold Bull 18:86–91

    Article  CAS  Google Scholar 

  • Villiers C, Freitas H, Couderc R, Villiers MB, Marche P (2010) Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions. J Nanopart Res 12:55–60

    Article  CAS  Google Scholar 

  • Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M (2010) Synthetic therapeutic peptides: science and market. Drug Discov Today 15(1-2):40–56

    Article  CAS  Google Scholar 

  • Wang C, Zhu W, Luo Y, Wang BZ (2018) Gold nanoparticles conjugating recombinant influenza hemagglutinin trimers and flagellin enhanced mucosal cellular immunity. Nanomedicine 14(4):1349–1360

    Article  CAS  Google Scholar 

  • Yao M, He L, McClements DJ, Xiao H (2015) Uptake of gold nanoparticles by intestinal epithelial cells: impact of particle size on their absorption, accumulation, and toxicity. J Agric Food Chem 63(36):8044–8049

    Article  CAS  Google Scholar 

  • Zhang D, Neumann O, Wang H et al (2009) Gold nanoparticles can induce the formation of protein-based aggregates at physiological pH. Nano Lett 9:666–671

    Article  CAS  Google Scholar 

  • Zhang L, Hu C, Yang W, Liu X, Wu Y (2016) Chemical synthesis, versatile structures and functions of tailorable adjuvants for optimizing Oral vaccination. ACS Appl Mater Interfaces 8(51):34933–34950

    Article  CAS  Google Scholar 

  • Zhang L, Yang W, Hu C, Wang Q, Wu Y (2018) Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination. Int J Nanomedicine 13:2973–2987

    Article  CAS  Google Scholar 

  • Zhou N, Wang J, Chen T et al (2006) Enlargement of gold nanoparticles on the surface of a self-assembled monolayer modified electrode: a mode in biosensor design. Anal Chem 78:5227–5230

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Facultad de Ciencias Químicas, Centro de Investigación en Ciencias de la Salud y Biomedicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico

    Sergio Rosales-Mendoza

  2. Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí , San Luis Potosí, Mexico

    Omar González-Ortega

Authors
  1. Sergio Rosales-Mendoza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Omar González-Ortega
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rosales-Mendoza, S., González-Ortega, O. (2019). Gold-Based Mucosal Nanovaccines. In: Nanovaccines. Springer, Cham. https://doi.org/10.1007/978-3-030-31668-6_3

Download citation

Publish with us

Policies and ethics

Search

Navigation